Promising combo targets rare ovarian tumors
NCT ID NCT05872204
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study tests whether a combination of two drugs, abemaciclib and letrozole, can shrink or control rare types of ovarian cancer that are fueled by estrogen. About 100 participants with low-grade serous ovarian cancer or granulosa cell tumors will receive the treatment. The goal is to see how well the tumors respond and how long the benefit lasts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW GRADE SEROUS OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Liège
RECRUITINGLiège, Liège, 4000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Leon Berard
RECRUITINGLyon, Métropole de Lyon, 69008, France
Contact Email: •••••@•••••
Contact
-
Erasmus Medical Center Rotterdam
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
Contact Email: •••••@•••••
Contact
-
Groupe Hospitalier Diaconesses Croix Saint Simon
RECRUITINGParis, Île-de-France Region, 75020, France
Contact Email: •••••@•••••
Contact
-
Institut Bergonie
RECRUITINGBordeaux, Gironde, 33000, France
Contact Email: •••••@•••••
Contact
-
Institut De Cancerologie De L'Ouest
RECRUITINGSaint-Herblain, Loire-Atlantique, 44800, France
Contact Email: •••••@•••••
Contact
-
Institut De Cancerologie Strasbourg Europe
RECRUITINGStrasbourg, Bas-Rhin, 67200, France
Contact Email: •••••@•••••
Contact
-
Institut Universitaire Du Cancer Toulouse-Oncopole
RECRUITINGToulouse, Haute-Garonne, 31059, France
Contact Email: •••••@•••••
Contact
-
UZ Gent
RECRUITINGGhent, Oost-Vlaanderen, 9000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UZ Leuven
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Medical Center Groningen
NOT_YET_RECRUITINGGroningen, Provincie Groningen, 9713 GZ, Netherlands
Contact Email: •••••@•••••
Contact
-
University Medical Center Utrecht
NOT_YET_RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.